Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
Best practices on advance notice of importation process for cosmetics and drugs The advance notice of importation process applies to the import of cosmetics and drugs, including natural health products (NHPs), that need to be modified or re-labelled to be sold legally in Canada.…
Annex 17, Parametric Release (PIC/S) - Guide to Good Manufacturing Practice for Medicinal Products Annexes Cover letter and PDF version 1. Principle 1.1 The definition of Parametric Release used in this Annex is based on that proposed by the European Organization for Quality: "A…
Annex 13 to the Good manufacturing practices guide for drugs used in clinical trials (GUI-0036): Overview Overview Guidance Glossary References Regulations referenced in this document Disclaimer: This document does not constitute part of the Food and Drugs Act (the Act) or its…
Annex 11 to the good manufacturing practices guide: Computerized Systems: GUI-0050 Download in PDF format (1.21 MB, 16 pages) Organization: Health Canada Published: August 10, 2021 Disclaimer This document does not constitute part of the Food and Drugs Act (the Act) or its…
Guidance Document Annex 4 to the Current Edition of the Good Manufacturing Practices Guidelines - Veterinary Drugs (GUI-0012) Overview Veterinary drugs Non-sterile, non-prescription veterinary drugs Veterinary drug premixes Definitions References Date issued: November 4, 2024…
Good manufacturing practices guidelines for active pharmaceutical ingredients (GUI-0104) - Summary Guidance on Drug Establishment Licences (GUI-0002) Guidance: How to demonstrate foreign building compliance with drug good manufacturing practices (GUI-0080) Risk classification…
Archived DEL and GMP temporary measures due to COVID-19 Health Canada has reviewed the good manufacturing practices and drug establishment licence temporary regulatory flexibilities we put in place during the pandemic. Our review process involves many considerations, including…
Regulations Regulations Amending the Food and Drug Regulations (1024 - Clinical Trials) Page details 2017-05-04
Good clinical practices: Guidance documents Guidance Document: Part C, Division 5 of the Food and Drug Regulations "Drugs for Clinical Trials Involving Human Subjects" (GUI-0100) Risk classification guide for observations related to inspections of clinical trials of human drugs…
Consultation on “Drugs for Clinical Trials Involving Human Subjects” (GUI-0100: Guidance Document – Part C, Division 5 of the Food and Drug Regulations) From Health Canada Current status: Closed Between December 15th, 2017 and April 15th, 2018 Health Canada is seeking input from…
Early release: coverage is bounded to the current corpus, and features may change.
